Menu
Search for
Log In
Topics
AI & Technology
Agentic
Analytics
Automation
Blockchain
Cloud
Computer Vision
Conversational AI
Cyber Security
Data
Digital Transformation
Ethics & Responsibility
Future of AI
IoT
Machine Learning
Metaverse
Natural Language Processing (NLP)
Responsible AI
Robotics
Sectors & Use Cases
Automotive
Education
Energy
Finance
Gaming
Healthcare
Insurance
Manufacturing
Property & Real Estate
Public Sector
Retail
Sports
Supply Chain & Logistics
Telecommunications
AI Business Strategy
Digital Transformation
Environment & Sustainability
Ethics & Responsibility
HR, Workforce, and Skills
Legal & Compliance
Marketing & Customer
Product & Revenue
Policy & Regulation
AI Leadership & Perspective
Boardroom & Governance
C-Suite Perspective
Community Voices
Founder & Investor Voices
Innovation Spotlight
Interview
Leadership Vision
Strategic Partnerships
Columnists
The Control Layer By Victor Dey
Learn
Events
Newsletter
Reports & Guides
Webinars
Media Kit
Premium
Login
Contact Us
Search for
Home
/
Press release
Press release
Press Release
Cision PR Newswire
11 February 2026
New TELUS Digital Poll and Research Paper Find that AI Accuracy Rarely Improves When Questioned
Read More »
Press Release
Cision PR Newswire
11 February 2026
Hyperliquid Strategies Inc Reports Financial Results for the Quarter Ended December 31, 2025
Read More »
Cision PR Newswire
11 February 2026
Einride Joins the European Connected and Autonomous Vehicle Alliance (ECAVA)
Read More »
Business Wire
11 February 2026
GCT Semiconductor Partners with Skylo to Accelerate Global Satellite Connectivity
Read More »
Business Wire
11 February 2026
Ryder Reports Fourth Quarter 2025 Results and Provides 2026 Outlook
Read More »
Business Wire
11 February 2026
AECOM to provide detailed design services to support delivery of Sydney Metro West
Read More »
Business Wire
11 February 2026
CHIMERA INVESTMENT CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2025 EARNINGS
Read More »
Business Wire
11 February 2026
Ferguson to Issue Results for the Period Ended December 31, 2025, as well as provide an Update on Market Opportunities and Strategy on February 24, 2026
Read More »
Business Wire
11 February 2026
KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment
Read More »
Business Wire
11 February 2026
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
Read More »
Previous page
Next page
Back to top button
Close
Search for
Close
Search for
Close
Log In
Forget?
Remember me
Log In
